Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls

被引:44
作者
Haghighi, S [1 ]
Andersen, O
Rosengren, L
Bergström, T
Wahlström, J
Nilsson, S
机构
[1] Sahlgrens Univ Hosp, Inst Clin Neurosci, S-41345 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Inst Virol, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Inst Clin Genet, Gothenburg, Sweden
[4] Chalmers Univ Technol, Inst Stat Math, S-41296 Gothenburg, Sweden
关键词
multiple sclerosis; siblings; genetics; oligoclonal bands; measles;
D O I
10.1007/s004150070130
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We found that 19% (9/47) of healthy siblings of patients with clinically definite multiple sclerosis had an intrathecal immunological reaction with two or more 2 CSF-enriched oligoclonal bands (OCBs), in contrast to (4%) (2/50) unrelated healthy controls. Furthermore, in this group of nine healthy sibs the measles CSF IgG antibody titers were higher than that of the other sibs and that of controls. Then were also differences in the serum titers for measles IgG antibody, which were higher in the group of all healthy sibs than in healthy volunteers, and (as with CSF titers) higher in the subgroup of healthy sibs with two or more 2 CSF-enriched OCBs than the other sibs. Thus a significant proportion of healthy siblings to MS patients have a partially hyperimmune condition similar to that occur-ring in MS, which in 19% manifested itself as an OCB reaction, in 9 % as increased CSF measles IgG antibody titers, and in 21 % as increased serum measles IgG antibody titers, these phenomena tending to occur in the same individuals. This condition is characterized by CSF-enriched OCBs with undefined specificity, although some increased antiviral reactivity is found both in the serum and CSF While it needs further characterization, a genetic trait interacting with common infections is suggested. The recurrence risk of this condition is approximately five times higher than the 3-4% recurrence risk for manifest MS reported for sibs.
引用
收藏
页码:616 / 622
页数:7
相关论文
共 34 条
[1]  
ADAMS JM, 1962, P SOC EXP BIOL MED, V111, P562, DOI 10.3181/00379727-111-27855
[2]   TISSUE TYPING OF CSF LYMPHOCYTES IN MS [J].
ANDERSEN, O ;
LINDHOLM, A .
ACTA NEUROLOGICA SCANDINAVICA, 1976, 54 (05) :464-466
[3]  
ANDERSEN O, 1999, ADV MULTIPLE SCLEROS
[4]   PRIMARY AND RECURRENT HERPES-SIMPLEX VIRUS TYPE-2-INDUCED MENINGITIS [J].
BERGSTROM, T ;
VAHLNE, A ;
ALESTIG, K ;
JEANSSON, S ;
FORSGREN, M ;
LYCKE, E .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (02) :322-330
[5]   FORMULAS FOR THE QUANTITATION OF INTRATHECAL IGG PRODUCTION - THEIR VALIDITY IN THE PRESENCE OF BLOOD-BRAIN-BARRIER DAMAGE AND THEIR UTILITY IN MULTIPLE-SCLEROSIS [J].
BLENNOW, K ;
FREDMAN, P ;
WALLIN, A ;
GOTTFRIES, CG ;
FREY, H ;
PIRTTILA, T ;
SKOOG, I ;
WIKKELSO, C ;
SVENNERHOLM, L .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 121 (01) :90-96
[6]   VIRUS ANTIBODY TITERS IN MULTIPLE SCLEROSIS PATIENTS, SIBLINGS, AND CONTROLS [J].
BRODY, JA ;
SEVER, JL ;
HENSON, TE .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 216 (09) :1441-&
[7]   SIGNIFICANCE OF REACTIVE LYME SEROLOGY IN MULTIPLE-SCLEROSIS [J].
COYLE, PK ;
KRUPP, LB ;
DOSCHER, C .
ANNALS OF NEUROLOGY, 1993, 34 (05) :745-747
[8]   A POPULATION-BASED STUDY OF MULTIPLE-SCLEROSIS IN TWINS [J].
EBERS, GC ;
BULMAN, DE ;
SADOVNICK, AD ;
PATY, DW ;
WARREN, S ;
HADER, W ;
MURRAY, TJ ;
SELAND, TP ;
DUQUETTE, P ;
GREY, T ;
NELSON, R ;
NICOLLE, M ;
BRUNET, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (26) :1638-1642
[9]   A GENETIC-BASIS FOR FAMILIAL AGGREGATION IN MULTIPLE-SCLEROSIS [J].
EBERS, GC ;
SADOVNICK, AD ;
RISCH, NJ ;
BULMAN, D ;
RICE, GPA ;
HASHIMOTO, SA ;
PATY, D ;
OGER, JJF ;
METZ, L ;
BELL, R ;
WARREN, S ;
HADER, W ;
AUTY, T ;
NATH, A ;
GRAY, T ;
OCONNOR, P ;
NELSON, R ;
FREEDMAN, M ;
BRUNET, D ;
PAULSETH, R ;
FRANCIS, G ;
DUQUETTE, P ;
MURRAY, TJ ;
BAHN, V ;
PRYSEPHILLIPS, W .
NATURE, 1995, 377 (6545) :150-151
[10]   THE DIAGNOSTIC-SIGNIFICANCE OF ANTIBODY SPECIFICITY INDEXES IN MULTIPLE-SCLEROSIS AND HERPES-VIRUS INDUCED DISEASES OF THE NERVOUS-SYSTEM [J].
FELGENHAUER, K ;
REIBER, H .
CLINICAL INVESTIGATOR, 1992, 70 (01) :28-37